Beta Bionics (BBNX) Cash from Investing Activities (2024 - 2026)

Beta Bionics has disclosed Cash from Investing Activities across 3 years of filings, most recently posting $26.9 million for Q2 2026.

• In Q2 2026, Cash from Investing Activities rose 336.3% year-over-year to $26.9 million; the TTM figure through Jun 2026 stood at $58.9 million (up 131.44% YoY), while the FY2025 annual figure was -$162.8 million, down 4583.69% from the prior year.
• Cash from Investing Activities came in at $26.9 million for Q2 2026 at Beta Bionics, up from $21.8 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $26.9 million in Q2 2026 to a low of -$179.1 million in Q1 2025.
• Average Cash from Investing Activities over 3 years is -$11.8 million, with a median of $6.9 million recorded in 2024.
• Year-over-year, Cash from Investing Activities plunged 2443.3% in 2025 and soared 336.3% in 2026.
• Over 3 years, Cash from Investing Activities stood at -$29.7 million in 2024, then surged by 102.22% to $658000.0 in 2025, then soared by 3993.16% to $26.9 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were $26.9 million in Q2 2026, $21.8 million in Q1 2026, and $658000.0 in Q4 2025.